ERBB2 and breast cancer: It has been reported that the immunophilin Pin1 is overexpressed in breast cancer and that its up-regulation is prevalent in ERBB2-positive tumours52,53; however, its silencing or functional inhibition does not potentiate TZ activity, possibly because it accelerates receptor degradation54.